IBI: AT223; Milan Obradović***, naučni savetnik, Univerzitet u Beogradu, Institut za nuklearne nauke 'Vinča'; Polje: prirodno-matematičke i medicinske nauke; Period: 2020-2024;
eNauka profil: rp07836; ORCID: 0000-0002-4769-2652;
WOS indikatori: NR = 78; TC = 2633; HIndex = 25;
eNauka WOS indikatori: NR = 80; TC = 2497; HIndex = 25 ;
Lista A broj bodova: 156.74139 (552) 25.2%; Lista B broj bodova: 1728.9836 (552) 6.5%; Lista C broj bodova: 0.000 (0) nan%; Lista A broj bodova kolaboracije: 0.000 (0) nan%; Lista B broj bodova kolaboracije: 0.000 (0) nan%;
Statistika svih rezultata
| Statistika | Ukupno | 2013-2024 | 2015-2024 | 2018-2024 | 2020-2024 |
|---|---|---|---|---|---|
| Broj rezultata | 78 | 70 | 60 | 41 | 28 |
| Broj citata | 2633 | 1953 | |||
| Broj M bodova | 179.00 | 179 | 179.00 | 179 | |
| Normirani broj citata | 2313.29 | 1728.98 | |||
| Normirani broj M bodova rezultata kategorije M21a++M21a+M21+M22+M23+M24 | 156.74 | 156.74 | 156.74 | 156.74 | |
| Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M41 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M41+M42 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M51 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M43+M44 | 0.00 | 0.00 | 0.00 | 0.00 |
Statistika rezultata nastalih u medunarodnim kolaboracijama
| Statistika | Ukupno | 2013-2024 | 2015-2024 | 2018-2024 | 2020-2024 |
|---|---|---|---|---|---|
| Broj rezultata sa 20 i više autora | 1 | 0 | 0 | 0 | 0 |
| Broj citata rezultata sa 20 i više autora | 1 | 0 | |||
| Broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora | 0.00 | 0 | 0.00 | 0 | |
| Normirani broj citata rezultata sa 20 i više autora | 0.01 | 0.00 | |||
| Normirani broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora | 0.00 | 0.00 |
Rezultati
| RB | IBI | Godina | Kat | Tip | Vrsta | Referenca | TC | TCP | BA | NBB | NTC | Naslov | Autori | 1. | AT223 | 2011 | E | ANGIOLOGY Vol. 62 (7): # 523 - 534 (12), (DOI: 10.1177/0003319711401012) OCT 2011WOS | 31 | 17 | 10 | 0 | 10.6250 | Peroxisome Proliferator-Activated Receptors and Atherosclerosis | Soskic S, Dobutovic B, Sudar E, Obradovic M, Nikolic D, Zaric B, Stojanovic S, Stokic E, Mikhailidis D, Isenovic E | 2. | AT223 | 2011 | E | CURRENT MEDICINAL CHEMISTRY Vol. 18 (22): # 3382 - 3386 (5), (DOI: 10.2174/092986711796504709) AUG 2011WOS | 9 | 5 | 6 | 0 | 5.0000 | Involvement of the ADAM 12 in Thrombin-Induced Rat's VSMCs Proliferation | Smiljanic K, Dobutovic B, Obradovic M, Nikolic D, Marche P, Isenovic E | 3. | AT223 | 2011 | E | OPEN CARDIOVASCULAR MEDICINE JOURNAL Vol. 5 (): # 153 - 163 (11), (DOI: 10.2174/1874192401105010153) 2011WOS | 137 | 110 | 9 | 0 | 78.5714 | Regulation of Inducible Nitric Oxide Synthase (iNOS) and its Potential Role in Insulin Resistance, Diabetes and Heart Failure | Soskic S, Dobutovic B, Sudar E, Obradovic M, Nikolic D, Djordjevic J, Radak D, Mikhailidis D, Isenovic E | 4. | AT223 | 2013 | E | JOURNAL OF ENDOCRINOLOGY Vol. 218 (3): # R13 - R23 (11), (DOI: 10.1530/JOE-13-0144) SEP 2013WOS | 30 | 26 | 8 | 0 | 21.6667 | Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases | Obradovic M, Bjelogrlic P, Rizzo M, Katsiki N, Haidara M, Stewart A, Jovanovic A, Isenovic E | 5. | AT223 | 2013 | E | CURRENT PHARMACEUTICAL DESIGN Vol. 19 (27): # 4953 - 4963 (11), (DOI: 10.2174/1381612811319270018) AUG 2013WOS | 25 | 22 | 9 | 0 | 15.7143 | A Review of the Cardiovascular and Anti-Atherogenic Effects of Ghrelin | Rizzo M, Rizvi A, Sudar E, Soskic S, Obradovic M, Montalto G, Boutjdir M, Mikhailidis D, Isenovic E | 6. | AT223 | 2013 | E | CURRENT PHARMACEUTICAL DESIGN Vol. 19 (21): # 3869 - 3877 (9), (DOI: 10.2174/13816128113199990303) JUN 2013WOS | 58 | 50 | 7 | 0 | 50.0000 | PCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders? | Banach M, Rizzo M, Obradovic M, Montalto G, Rysz J, Mikhailidis D, Isenovic E | 7. | AT223 | 2014 | E | MOLECULAR AND CELLULAR BIOCHEMISTRY Vol. 396 (1-2): # 147 - 160 (14), (DOI: 10.1007/s11010-014-2151-y) NOV 2014WOS | 32 | 30 | 8 | 0 | 25.0000 | RETRACTED: Thrombin stimulates VSMC proliferation through an EGFR-dependent pathway: involvement of MMP-2 (Retracted Article) | Smiljanic K, Obradovic M, Jovanovic A, Djordjevic J, Dobutovic B, Jevremovic D, Marche P, Isenovic E | 8. | AT223 | 2014 | E | MOLECULAR AND CELLULAR ENDOCRINOLOGY Vol. 388 (1-2): # 58 - 68 (11), (DOI: 10.1016/j.mce.2014.03.005) MAY 5 2014WOS | 25 | 23 | 10 | 0 | 14.3750 | In vivo effects of 17β-estradiol on cardiac Na+/K+-ATPase expression and activity in rat heart | Obradovic M, Stewart A, Pitt S, Labudovic-Borovic M, Sudar E, Petrovic V, Zafirovic S, Maravic-Stojkovic V, Vasic V, Isenovic E | 9. | AT223 | 2014 | E | ANGIOLOGY Vol. 65 (2): # 122 - 129 (8), (DOI: 10.1177/0003319712473637) FEB 2014WOS | 17 | 16 | 8 | 0 | 13.3333 | Copeptin Level After Carotid Endarterectomy and Perioperative Stroke | Maravic-Stojkovic V, Lausevic-Vuk L, Obradovic M, Jovanovic P, Tanaskovic S, Stojkovic B, Isenovic R, Radak D | 10. | AT223 | 2014 | E | ANGIOLOGY Vol. 65 (9): # 769 - 772 (4), (DOI: 10.1177/0003319713508642) OCT 2014WOS | 17 | 17 | 4 | 0 | 17.0000 | Practical Use of Near-Infrared Spectroscopy in Carotid Surgery | Radak D, Sotirovic V, Obradovic M, Isenovic E | 11. | AT223 | 2014 | E | CURRENT VASCULAR PHARMACOLOGY Vol. 12 (4): # 572 - 585 (14), (DOI: 10.2174/1570161111999131205160756) 2014WOS | 20 | 18 | 8 | 0 | 15.0000 | Uric Acid Metabolism in Pre-hypertension and the Metabolic Syndrome | Rizzo M, Obradovic M, Labudovic-Borovic M, Nikolic D, Montalto G, Rizvi A, Mikhailidis D, Isenovic E | 12. | AT223 | 2014 | E | CLINICAL LIPIDOLOGY Vol. 9 (5): # 505 - 513 (9), (DOI: 10.2217/CLP.14.42) 2014WOS | 5 | 4 | 8 | 0 | 3.3333 | Association of leptin gene polymorphism G-2548A with metabolic and anthropometric parameters in obese patients in a Serbian population: pilot study | Soskic S, Stokic E, Obradovic M, Sudar E, Tanic N, Kupusinac A, Djordjevic J, Isenovic E | 13. | AT223 | 2014 | E | CURRENT PHARMACEUTICAL DESIGN Vol. 20 (31): # 4961 - 4969 (9), (DOI: ) 2014WOS | 79 | 74 | 7 | 0 | 74.0000 | Resistin: An Inflammatory Cytokine. Role in Cardiovascular Diseases, Diabetes and the Metabolic Syndrome | Abate N, Sallam H, Rizzo M, Nikolic D, Obradovic M, Bjelogrlic P, Isenovic E | 14. | AT223 | 2015 | E | MOLECULAR AND CELLULAR ENDOCRINOLOGY Vol. 416 (C): # 46 - 56 (11), (DOI: 10.1016/j.mce.2015.08.020) NOV 15 2015WOS | 15 | 14 | 7 | 0 | 14.0000 | Effects of 17β-estradiol on cardiac Na+/K+-ATPase in high fat diet fed rats | Obradovic M, Zafirovic S, Jovanovic A, Milovanovic E, Mousa S, Labudovic-Borovic M, Isenovic E | 15. | AT223 | 2015 | E | ANGIOLOGY Vol. 66 (1): # 25 - 35 (11), (DOI: 10.1177/0003319713514477) JAN 2015WOS | 26 | 25 | 6 | 0 | 25.0000 | Estradiol In Vivo Induces Changes in Cardiomyocytes Size in Obese Rats | Obradovic M, Sudar E, Zafirovic S, Stanimirovic J, Labudovic-Borovic M, Isenovic E | 16. | AT223 | 2015 | E | CLINICAL CHEMISTRY AND LABORATORY MEDICINE Vol. 53 (1): # 29 - 34 (6), (DOI: 10.1515/cclm-2014-0590) JAN 2015WOS | 19 | 18 | 8 | 0 | 15.0000 | Interrelatedness between C-reactive protein and oxidized low-density lipoprotein | Obradovic M, Trpkovic A, Bajic V, Soskic S, Jovanovic A, Stanimirovic J, Panic M, Isenovic E | 17. | AT223 | 2015 | E | CURRENT VASCULAR PHARMACOLOGY Vol. 13 (5): # 658 - 669 (12), (DOI: 10.2174/1570161113666150212151506) 2015WOS | 11 | 11 | 6 | 0 | 11.0000 | Heart Failure Models: Traditional and Novel Therapy | Haidara M, Assiri A, Yassin H, Ammar H, Obradovic M, Isenovic E | 18. | AT223 | 2015 | E | CURRENT VASCULAR PHARMACOLOGY Vol. 13 (2): # 226 - 228 (3), (DOI: 10.2174/1570161113999150311153109) 2015WOS | 2 | 0 | 4 | 0 | 0.0000 | Oxidative Stress in Pathophysiological Conditions | Obradovic M, Bogdanovic N, Radak D, Isenovic E | 19. | AT223 | 2015 | E | CLINICAL LIPIDOLOGY Vol. 10 (2): # 167 - 175 (9), (DOI: 10.2217/CLP.15.8) 2015WOS | 14 | 13 | 8 | 0 | 10.8333 | Effects of altered hepatic lipid metabolism on regulation of hepatic iNOS | Stanimirovic J, Obradovic M, Zafirovic S, Resanovic I, Bogdanovic N, Gluvic Z, Mousa S, Isenovic E | 20. | AT223 | 2015 | E | LETTERS IN DRUG DESIGN & DISCOVERY Vol. 12 (2): # 158 - 164 (7), (DOI: ) 2015WOS | 3 | 3 | 7 | 0 | 3.0000 | Non-Classical Therapeutic Approach in the Treatment of Alzheimer's Disease: A Mini Review | Bajic V, Spremo-Potparevic B, Zivkovic L, Sudar E, Zafirovic S, Obradovic M, Isenovic E | 21. | AT223 | 2016 | E | NITRIC OXIDE-BIOLOGY AND CHEMISTRY Vol. 54 (): # 51 - 59 (9), (DOI: 10.1016/j.niox.2016.02.007) APR 1 2016WOS | 32 | 28 | 8 | 0 | 23.3333 | A high fat diet induces sex-specific differences in hepatic lipid metabolism and nitrite/nitrate in rats | Stanimirovic J, Obradovic M, Jovanovic A, Sudar-Milovanovic E, Zafirovic S, Pitt S, Stewart A, Isenovic E | 22. | AT223 | 2016 | E | MINI-REVIEWS IN MEDICINAL CHEMISTRY Vol. 16 (2): # 94 - 103 (10), (DOI: 10.2174/1389557515666151016125826) 2016WOS | 30 | 24 | 8 | 0 | 20.0000 | Benefits of L-Arginine on Cardiovascular System | Sudar-Milovanovic E, Obradovic M, Jovanovic A, Zaric B, Zafirovic S, Panic A, Radak D, Isenovic E | 23. | AT223 | 2016 | E | CURRENT VASCULAR PHARMACOLOGY Vol. 14 (3): # 266 - 270 (5), (DOI: 10.2174/1570161114666160208143537) 2016WOS | 22 | 19 | 8 | 0 | 15.8333 | Nitric Oxide as a Marker for Levo-Thyroxine Therapy in Subclinical Hypothyroid Patients | Obradovic M, Gluvic Z, Sudar-Milovanovic E, Panic A, Trebaljevac J, Bajic V, Zarkovic M, Isenovic E | 24. | AT223 | 2017 | E | MOLECULAR AND CELLULAR BIOCHEMISTRY Vol. 436 (1-2): # 49 - 58 (10), (DOI: 10.1007/s11010-017-3077-y) DEC 2017WOS | 7 | 5 | 8 | 0 | 4.1667 | Changes in cardiac Na+/K+-ATPase expression and activity in female rats fed a high-fat diet | Jovanovic A, Obradovic M, Milovanovic E, Stewart A, Pitt S, Alavantic D, Aleksic E, Isenovic E | 25. | AT223 | 2017 | E | MOLECULAR AND CELLULAR ENDOCRINOLOGY Vol. 446 (C): # 12 - 20 (9), (DOI: 10.1016/j.mce.2017.02.001) MAY 5 2017WOS | 13 | 12 | 8 | 0 | 10.0000 | 17β-Estradiol protects against the effects of a high fat diet on cardiac glucose, lipid and nitric oxide metabolism in rats | Zafirovic S, Obradovic M, Sudar-Milovanovic E, Jovanovic A, Stanimirovic J, Stewart A, Pitt S, Isenovic E | 26. | AT223 | 2017 | E | ROMANIAN JOURNAL OF INTERNAL MEDICINE Vol. 55 (3): # 129 - 137 (9), (DOI: 10.1515/rjim-2017-0014) SEP 2017WOS | 4 | 2 | 7 | 0 | 2.0000 | A quality of life assessment and the correlation between generic and disease-specific questionnaires scores in outpatients with chronic liver disease-pilot study | Obradovic M, Gluvic Z, Petrovic N, Obradovic M, Tomasevic R, Dugalic P, Isenovic E | 27. | AT223 | 2017 | E | CURRENT PHARMACEUTICAL DESIGN Vol. 23 (10): # 1427 - 1434 (8), (DOI: 10.2174/1381612823666170124124855) 2017WOS | 12 | 12 | 7 | 0 | 12.0000 | Hormonal Regulation of Nitric Oxide (NO) in Cardio-metabolic Diseases | Sudar-Milovanovic E, Zafirovic S, Jovanovic A, Trebaljevac J, Obradovic M, Cenic-Milosevic D, Isenovic E | 28. | AT223 | 2017 | E | CURRENT PHARMACEUTICAL DESIGN Vol. 23 (10): # 1551 - 1561 (11), (DOI: 10.2174/1381612823666170203113455) 2017WOS | 16 | 15 | 7 | 0 | 15.0000 | Regulation of Na+/K+-ATPase by Estradiol and IGF-1 in Cardio-Metabolic Diseases | Obradovic M, Stanimirovic J, Panic A, Bogdanovic N, Sudar-Milovanovic E, Cenic-Milosevic D, Isenovic E | 29. | AT223 | 2017 | E | CURRENT VASCULAR PHARMACOLOGY Vol. 15 (1): # 30 - 39 (10), (DOI: 10.2174/1570161114666161007164510) 2017WOS | 200 | 173 | 7 | 0 | 173.0000 | Link between Metabolic Syndrome and Insulin Resistance | Gluvic Z, Zaric B, Resanovic I, Obradovic M, Mitrovic A, Radak D, Isenovic E | 30. | AT223 | 2017 | E | CURRENT VASCULAR PHARMACOLOGY Vol. 15 (5): # 491 - 500 (10), (DOI: 10.2174/1570161114666161025101303) 2017WOS | 15 | 13 | 9 | 0 | 9.2857 | Influence of a High-fat Diet on Cardiac iNOS in Female Rats | Jovanovic A, Sudar-Milovanovic E, Obradovic M, Pitt S, Stewart A, Zafirovic S, Stanimirovic J, Radak D, Isenovic E | 31. | AT223 | 2017 | E | CURRENT VASCULAR PHARMACOLOGY Vol. 15 (3): # 230 - 237 (8), (DOI: 10.2174/1570161115666170105121900) 2017WOS | 17 | 15 | 6 | 0 | 15.0000 | Should We be Concerned About the Inflammatory Response to Endovascular Procedures? | Radak D, Djukic N, Tanaskovic S, Obradovic M, Cenic-Milosevic D, Isenovic E | 32. | AT223 | 2017 | E | CANCER BIOMARKERS Vol. 19 (2): # 119 - 128 (10), (DOI: 10.3233/CBM-160319) 2017WOS | 55 | 50 | 5 | 0 | 50.0000 | MicroRNA in breast cancer: The association with BRCA1/2 | Petrovic N, Davidovic R, Bajic V, Obradovic M, Isenovic R | 33. | AT223 | 2018 | E | BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY Vol. 65 (6): # 797 - 806 (10), (DOI: 10.1002/bab.1680) NOV-DEC 2018WOS | 7 | 7 | 8 | 0 | 5.8333 | Estradiol-mediated regulation of hepatic iNOS in obese rats: Impact of Src, ERK1/2, AMPK, and miR-221 | Panic A, Stanimirovic J, Obradovic M, Sudar-Milovanovic E, Perovic M, Lackovic M, Petrovic N, Isenovic E | 34. | AT223 | 2018 | E | MOLECULAR AND CELLULAR BIOCHEMISTRY Vol. 440 (1-2): # 77 - 88 (12), (DOI: 10.1007/s11010-017-3157-z) MAR 2018WOS | 12 | 11 | 7 | 0 | 11.0000 | Regulation of hepatic Na+/K+-ATPase in obese female and male rats: involvement of ERK1/2, AMPK, and Rho/ROCK | Stanimirovic J, Obradovic M, Panic A, Petrovic V, Alavantic D, Melih I, Isenovic E | 35. | AT223 | 2018 | E | CURRENT DRUG TARGETS Vol. 19 (9): # 1058 - 1067 (10), (DOI: 10.2174/1389450119666171205101401) 2018WOS | 8 | 7 | 7 | 0 | 7.0000 | PCSK9 and Hypercholesterolemia: Therapeutic Approach | Obradovic M, Zaric B, Sudar-Milovanovic E, Ilincic B, Stokic E, Perovic M, Isenovic E | 36. | AT223 | 2018 | E | CURRENT VASCULAR PHARMACOLOGY Vol. 16 (4): # 361 - 362 (2), (DOI: 10.2174/1570161115999171004111230) 2018WOS | 1 | 1 | 4 | 0 | 1.0000 | Relationship between Vitamin D and Metalloproteinases (MMPs) in Acute Myocardial Infarction (AMI) | Perovic M, Obradovic M, Resanovic I, Isenovic E | 37. | AT223 | 2018 | E | MEDICINA-LITHUANIA Vol. 54 (3): #36 - (13), (DOI: 10.3390/medicina54030036) JUL 2018WOS | 14 | 13 | 7 | 0 | 13.0000 | Genetic Markers for Coronary Artery Disease | Veljkovic N, Zaric B, Djuric I, Obradovic M, Sudar-Milovanovic E, Radak D, Isenovic E | 38. | AT223 | 2018 | E | JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS Vol. 32 (6): # 1369 - 1377 (9), (DOI: ) NOV-DEC 2018WOS | 4 | 4 | 7 | 0 | 4.0000 | 17β-ESTRADIOL INHIBITS HEPATIC iNOS VIA THE ACTIVATION OF THE ESTROGEN RECEPTOR ER-α AND INHIBITION OF ERK1/2-miR-221 AXIS | Panic A, Stanimirovic J, Obradovic M, Zafirovic S, Sudar-Milovanovic E, Petrovic N, Isenovic E | 39. | AT223 | 2019 | E | MEDICAL HYPOTHESES Vol. 122 (): # 16 - 18 (3), (DOI: 10.1016/j.mehy.2018.10.011) JAN 2019WOS | 1 | 1 | 6 | 0 | 1.0000 | Hypothesis related to the regulation of inducible nitric oxide synthase during carotid endarterectomy | Obradovic M, Bogdanovic N, Stanimirovic J, Unic-Stojanovic D, Radak D, Isenovic E | 40. | AT223 | 2019 | E | MEDICAL HYPOTHESES Vol. 131 (): #109299 - (8), (DOI: 10.1016/j.mehy.2019.109299) OCT 2019WOS | 4 | 4 | 7 | 0 | 4.0000 | Serum nitric oxide levels correlate with quality of life questionnaires scores of hypothyroid females | Gluvic Z, Sudar-Milovanovic E, Samardzic V, Obradovic M, Jevremovic D, Radenkovic S, Isenovic E | 41. | AT223 | 2019 | E | OXIDATIVE MEDICINE AND CELLULAR LONGEVITY Vol. 2019 (): #5028181 - (14), (DOI: 10.1155/2019/5028181) 2019WOS | 121 | 101 | 8 | 0 | 84.1667 | Glutathione "Redox Homeostasis" and Its Relation to Cardiovascular Disease | Bajic V, Van N, Obradovic M, Zafirovic S, Radak D, Bajic V, Essack M, Isenovic E | 42. | AT223 | 2019 | E | CURRENT MEDICINAL CHEMISTRY Vol. 26 (16): # 2948 - 2961 (14), (DOI: 10.2174/0929867325666180313105949) 2019WOS | 186 | 146 | 6 | 0 | 146.0000 | Homocysteine and Hyperhomocysteinaemia | Zaric B, Obradovic M, Bajic V, Haidar M, Jovanovic M, Isenovic E | 43. | AT223 | 2019 | E | CURRENT PHARMACEUTICAL DESIGN Vol. 25 (2): # 166 - 173 (8), (DOI: 10.2174/1381612825666190306153838) 2019WOS | 26 | 21 | 6 | 0 | 21.0000 | Drug Delivery Systems for Diabetes Treatment | Zaric B, Obradovic M, Sudar-Milovanovic E, Nedeljkovic J, Lazic V, Isenovic E | 44. | AT223 | 2019 | E | CURRENT PHARMACEUTICAL DESIGN Vol. 25 (35): # 3715 - 3725 (11), (DOI: 10.2174/1381612825666191106091507) 2019WOS | 38 | 29 | 7 | 0 | 29.0000 | Effects of IGF-1 on the Cardiovascular System | Obradovic M, Zafirovic S, Soskic S, Stanimirovic J, Trpkovic A, Jevremovic D, Isenovic E | 45. | AT223 | 2019 | E | CURRENT VASCULAR PHARMACOLOGY Vol. 17 (3): # 307 - 318 (12), (DOI: 10.2174/1570161116666180212142414) 2019WOS | 5 | 4 | 7 | 0 | 4.0000 | Involvement of PI3K, Akt and RhoA in Oestradiol Regulation of Cardiac iNOS Expression | Zafirovic S, Sudar-Milovanovic E, Obradovic M, Djordjevic J, Jasnic N, Borovic M, Isenovic E | 46. | AT223 | 2020 | M21a | E | Review | BIOMEDICINE & PHARMACOTHERAPY Vol. 124 (): #109881 - (8), (DOI: 10.1016/j.biopha.2020.109881) APR 2020WOS | 26 | 20 | 9 | 8.5714 | 14.2857 | Regulation of nitric oxide production in hypothyroidism | Gluvic Z, Obradovic M, Sudar-Milovanovic E, Zafirovic S, Radak D, Essack M, Bajic V, Gojobori T, Isenovic E | 47. | AT223 | 2020 | M21 | E | Review | BIOFACTORS Vol. 46 (2): # 246 - 262 (17), (DOI: 10.1002/biof.1559) MAR 2020WOS | 18 | 16 | 10 | 5.0000 | 10.0000 | Redox control of vascular biology | Obradovic M, Essack M, Zafirovic S, Sudar-Milovanovic E, Bajic V, Van N, Trpkovic A, Stanimirovic J, Bajic V, Isenovic E | 48. | AT223 | 2020 | M21 | E | Review | CURRENT MEDICINAL CHEMISTRY Vol. 27 (7): # 1021 - 1040 (20), (DOI: 10.2174/0929867326666190903112146) 2020WOS | 32 | 25 | 6 | 8.0000 | 25.0000 | Endothelial Dysfunction in Dyslipidaemia: Molecular Mechanisms and Clinical Implications | Zaric B, Obradovic M, Trpkovic A, Banach M, Mikhailidis D, Isenovic E | 49. | AT223 | 2020 | M22 | E | Article | MEDICAL HYPOTHESES Vol. 134 (): #109419 - (5), (DOI: 10.1016/j.mehy.2019.109419) JAN 2020WOS | 1 | 1 | 9 | 3.5714 | 0.7143 | Antioxidant enzymes expression in lymphocytes of patients undergoing carotid endarterectomy | Obradovic M, Zafirovic S, Essack M, Dimitrov J, Zivkovic L, Spremo-Potparevic B, Radak D, Bajic V, Isenovic E | 50. | AT223 | 2020 | M22 | E | Review | JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS Vol. 45 (2): # 379 - 383 (5), (DOI: 10.1111/jcpt.13073) APR 2020WOS | 5 | 3 | 8 | 4.1667 | 2.5000 | HbA1C as a marker of retrograde glycaemic control in diabetes patient with co-existed beta-thalassaemia: A case report and a literature review | Gluvic Z, Obradovic M, Lackovic M, Samardzic V, Jevtic J, Essack M, Bajic V, Isenovic E | 51. | AT223 | 2020 | M22 | E | Review | MINI-REVIEWS IN MEDICINAL CHEMISTRY Vol. 20 (11): # 975 - 987 (13), (DOI: 10.2174/1389557519666191015203636) 2020WOS | 1 | 1 | 9 | 3.5714 | 0.7143 | Proton Pump Inhibitors and Radiofrequency Ablation for Treatment of Barrett's Esophagus | Dugalic P, Djuranovic S, Pavlovic-Markovic A, Dugalic V, Tomasevic R, Gluvic Z, Obradovic M, Bajic V, Isenovic E | 52. | AT223 | 2021 | M21 | E | Review | FRONTIERS IN ENDOCRINOLOGY Vol. 12 (): #585887 - (14), (DOI: 10.3389/fendo.2021.585887) MAY 18 2021WOS | 761 | 479 | 8 | 6.6667 | 399.1667 | Leptin and Obesity: Role and Clinical Implication | Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart A, Gojobori T, Isenovic E | 53. | AT223 | 2021 | M21 | E | Review | FRONTIERS IN ENDOCRINOLOGY Vol. 12 (): #758043 - (12), (DOI: 10.3389/fendo.2021.758043) NOV 4 2021WOS | 25 | 13 | 9 | 5.7143 | 9.2857 | Levothyroxine Treatment and the Risk of Cardiac Arrhythmias - Focus on the Patient Submitted to Thyroid Surgery | Gluvic Z, Obradovic M, Stewart A, Essack M, Pitt S, Samardzic V, Soskic S, Gojobori T, Isenovic E | 54. | AT223 | 2021 | M22 | E | Article | MEDICAL HYPOTHESES Vol. 150 (): #110569 - (4), (DOI: 10.1016/j.mehy.2021.110569) MAY 2021WOS | 3 | 2 | 5 | 5.0000 | 2.0000 | Could the level of nitrite/nitrate contribute to malignant thyroid nodule diagnostics? | Samardzic V, Banjac K, Obradovic M, Gluvic Z, Isenovic E | 55. | AT223 | 2021 | M22 | E | Review | CURRENT VASCULAR PHARMACOLOGY Vol. 19 (4): # 359 - 369 (11), (DOI: 10.2174/1570161118666200529111314) 2021WOS | 9 | 6 | 6 | 5.0000 | 6.0000 | Effects of Gentiana lutea Root on Vascular Diseases | Joksic G, Radak D, Sudar-Milovanovic E, Obradovic M, Radovanovic J, Isenovic E | 56. | AT223 | 2022 | M21 | E | Review | MEDIATORS OF INFLAMMATION Vol. 2022 (): #3706508 - (15), (DOI: 10.1155/2022/3706508) MAY 17 2022WOS | 116 | 53 | 9 | 5.7143 | 37.8571 | Role of C-Reactive Protein in Diabetic Inflammation | Stanimirovic J, Radovanovic J, Banjac K, Obradovic M, Essack M, Zafirovic S, Gluvic Z, Gojobori T, Isenovic E | 57. | AT223 | 2022 | M21 | E | Review | CURRENT MEDICINAL CHEMISTRY Vol. 29 (1): # 99 - 113 (15), (DOI: 10.2174/0929867328666210714153649) 2022WOS | 37 | 29 | 5 | 8.0000 | 29.0000 | Tryptophan Metabolism in Atherosclerosis and Diabetes | Sudar-Milovanovic E, Gluvic Z, Obradovic M, Zaric B, Isenovic E | 58. | AT223 | 2022 | M21 | E | Review | CURRENT VASCULAR PHARMACOLOGY Vol. 20 (6): # 465 - 474 (10), (DOI: 10.2174/1570161120666220819164240) 2022WOS | 3 | 2 | 7 | 8.0000 | 2.0000 | Association Between Telomere Length and Cardiovascular Risk: Pharmacological Treatments Affecting Telomeres and Telomerase Activity | Zafirovic S, Macvanin M, Stanimirovic J, Obradovic M, Radovanovic J, Melih I, Isenovic E | 59. | AT223 | 2022 | M22 | E | Article | ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS Vol. 22 (1): # 117 - 124 (8), (DOI: 10.2174/1871530321666210225110140) 2022WOS | 14 | 13 | 8 | 4.1667 | 10.8333 | Effects of Metformin-Single Therapy on the Level of Inflammatory Mark-ers in Serum of Non-Obese T2DM Patients with NAFLD | Mitrovic B, Gluvic Z, Macut D, Obradovic M, Sudar-Milovanovic E, Soskic S, Stajic D, Isenovic E | 60. | AT223 | 2022 | M22 | E | Review | CURRENT PHARMACEUTICAL DESIGN Vol. 28 (25): # 2065 - 2072 (8), (DOI: 10.2174/1381612828666220620160516) 2022WOS | 26 | 19 | 6 | 5.0000 | 19.0000 | Hypothyroidism and Risk of Cardiovascular Disease | Gluvic Z, Zafirovic S, Obradovic M, Sudar-Milovanovic E, Rizzo M, Isenovic E | 61. | AT223 | 2022 | M23 | E | Article | ACTA ENDOCRINOLOGICA-BUCHAREST Vol. 18 (4): # 480 - 487 (8), (DOI: 10.4183/aeb.2022.480) OCT-DEC 2022WOS | 2 | 2 | 7 | 3.0000 | 2.0000 | A NON-INVASIVE METHOD FOR ESTIMATING THE SEVERITY OF LIVER STEATOSIS AND THE RISK OF FIBROSIS IN NON-OBESE TYPE 2 DIABETES PATIENTS WITH NAFLD | Mitrovic B, Gluvic Z, Klisic A, Obradovic M, Macut D, Tomasevic R, Isenovic E | 62. | AT223 | 2022 | M24 | E | Review | EMERGENCY AND CRITICAL CARE MEDICINE Vol. 2 (1): # 12 - 22 (11), (DOI: 10.1097/EC9.0000000000000016) MAR 2022WOS | 4 | 3 | 5 | 0 | 3.0000 | Non-alcoholic fatty liver disease: a multidisciplinary clinical practice approach-the institutional adaptation to existing Clinical Practice Guidelines | Gluvic Z, Tomasevic R, Bojovic K, Obradovic M, Isenovic E | 63. | AT223 | 2023 | M21 | E | Article | MEDICAL HYPOTHESES Vol. 174 (): #111049 - (6), (DOI: 10.1016/j.mehy.2023.111049) MAY 2023WOS | 0 | 0 | 7 | 8.0000 | 0.0000 | Does oestradiol treatment alleviate obesity-induced oxidative stress in the male liver? | Panic A, Sudar-Milovanovic E, Stanimirovic J, Obradovic M, Zafirovic S, Soskic S, Isenovic E | 64. | AT223 | 2023 | M21 | E | Article | FRONTIERS IN ENDOCRINOLOGY Vol. 14 (): #1241223 - (11), (DOI: 10.3389/fendo.2023.1241223) SEP 28 2023WOS | 1 | 1 | 9 | 5.7143 | 0.7143 | Nitric oxide, thyroglobulin, and calcitonin: unraveling the nature of thyroid nodules | Samardzic V, Macvanin M, Zafirovic S, Obradovic M, Gluvic Z, Grubin J, Gao X, Essack M, Isenovic E | 65. | AT223 | 2023 | M21 | E | Article | ARCHIVES OF MEDICAL SCIENCE Vol. 19 (4): # 884 - 894 (11), (DOI: 10.5114/aoms/150639) 2023WOS | 51 | 16 | 7 | 8.0000 | 16.0000 | Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: where do we stand today? | Mitrovic B, Gluvic Z, Obradovic M, Radunovic M, Rizzo M, Banach M, Isenovic E | 66. | AT223 | 2023 | M21 | E | Article | EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES Vol. 27 (11): # 4980 - 4989 (10), (DOI: ) 2023WOS | 1 | 0 | 7 | 8.0000 | 0.0000 | Impact of treatment modalities on quality of life and depression in type 2 diabetes | Lackovic M, Macvanin M, Obradovic M, Gluvic Z, Sudar-Milovanovic E, Grujicic S, Isenovic E | 67. | AT223 | 2023 | M21 | E | Review | CURRENT MEDICINAL CHEMISTRY Vol. 30 (17): # 1922 - 1944 (23), (DOI: 10.2174/0929867329666220801161536) 2023WOS | 31 | 20 | 5 | 8.0000 | 20.0000 | The Role of miRNAs in Metabolic Diseases | Macvanin M, Obradovic M, Zafirovic S, Stanimirovic J, Isenovic E | 68. | AT223 | 2023 | M21 | E | Review | FRONTIERS IN ENDOCRINOLOGY Vol. 14 (): #1150171 - (12), (DOI: 10.3389/fendo.2023.1150171) FEB 28 2023WOS | 31 | 14 | 6 | 8.0000 | 14.0000 | The Na+/K+-ATPase: A potential therapeutic target in cardiometabolic diseases | Obradovic M, Sudar-Milovanovic E, Gluvic Z, Banjac K, Rizzo M, Isenovic E | 69. | AT223 | 2023 | M21 | E | Editorial Material | FRONTIERS IN ENDOCRINOLOGY Vol. 14 (): #1149857 - (3), (DOI: 10.3389/fendo.2023.1149857) FEB 6 2023WOS | 1 | 1 | 4 | 0 | 1.0000 | Non-coding RNA in diabetes and cardiovascular diseases | Macvanin M, Zafirovic S, Obradovic M, Isenovic E | 70. | AT223 | 2024 | M21a | E | Article | ARCHIVES OF MEDICAL SCIENCE Vol. 20 (3): # 1011 - 1015 (5), (DOI: 10.5114/aoms/177618) 2024WOS | 1 | 0 | 4 | 12.0000 | 0.0000 | Insulin-like growth factor-1 reduces cardiac autosis through decreasing AMPK/FOXO1 signaling and Na+/K+-ATPase-Beclin-1 interaction | Banjac K, Obradovic M, Zafirovic S, Isenovic E | 71. | AT223 | 2024 | M21 | E | Article | MOLECULAR AND CELLULAR ENDOCRINOLOGY Vol. 592 (): #112325 - (12), (DOI: 10.1016/j.mce.2024.112325) OCT 1 2024WOS | 0 | 0 | 9 | 5.7143 | 0.0000 | Impact of different hormones on the regulation of nitric oxide in diabetes | Gluvic Z, Obradovic M, Manojlovic M, Giglio R, Patti A, Ciaccio M, Suri J, Rizzo M, Isenovic E | 72. | AT223 | 2024 | M22 | E | Article | MOLECULAR BIOLOGY REPORTS Vol. 51 (1): #517 - (12), (DOI: 10.1007/s11033-024-09451-3) DEC 2024WOS | 2 | 1 | 8 | 4.1667 | 0.8333 | The involvement of Akt, mTOR, and S6K in the in vivo effect of IGF-1 on the regulation of rat cardiac Na+/K+-ATPase | Banjac K, Obradovic M, Zafirovic S, Essack M, Gluvic Z, Sunderic M, Nedic O, Isenovic E | 73. | AT223 | 2024 | M22 | E | Retraction | MOLECULAR AND CELLULAR BIOCHEMISTRY Vol. 479 (9): # 2497 - 2497 (1), (DOI: 10.1007/s11010-024-05016-x) SEP 2024WOS | 0 | 0 | 8 | 0 | 0.0000 | RETRACTION: Thrombin stimulates VSMC proliferation through an EGFR-dependent pathway: involvement of MMP-2 (Retraction of Vol 396, Pg 147, 2014) | Smiljanic K, Obradovic M, Jovanovic A, Djordjevic J, Dobutovic B, Jevremovic D, Marche P, Isenovic E | 74. | AT223 | 2025 | E | BUILDING AND ENVIRONMENT Vol. 270 (): #112509 - (10), (DOI: 10.1016/j.buildenv.2024.112509) FEB 15 2025WOS | 2 | 0 | 4 | 0 | 0.0000 | Source-specific probabilistic exposure to PM2.5-bound trace elements in a school environment | Obradovic J, Jovasevic-Stojanovic M, Obradovic M, Onjia A | 75. | AT223 | 2025 | E | BUILDING AND ENVIRONMENT Vol. 279 (): #113050 - (11), (DOI: 10.1016/j.buildenv.2025.113050) JUL 1 2025WOS | 2 | 0 | 5 | 0 | 0.0000 | Two-dimensional Monte Carlo simulation of source-specific risks from PM2.5-bound polycyclic aromatic hydrocarbons in indoor and outdoor school environments | Obradovic J, Veskovic J, Jovasevic-Stojanovic M, Obradovic M, Onjia A | 76. | AT223 | 2025 | E | PEPTIDES Vol. 190 (): #171418 - (11), (DOI: 10.1016/j.peptides.2025.171418) AUG 2025WOS | 1 | 0 | 4 | 0 | 0.0000 | IGF-1 contributes to cardiovascular protection in obesity by upregulating Na plus /K plus -ATPase activity and modulating key signaling pathways in rats on a high-fat diet | Banjac K, Obradovic M, Zafirovic S, Isenovic E | 77. | AT223 | 2025 | E | SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION Vol. 85 (1): # 51 - 57 (7), (DOI: 10.1080/00365513.2025.2460034) JAN 2 2025WOS | 0 | 0 | 7 | 0 | 0.0000 | A pilot study on the relationship between zinc deficiency and anthropometric and metabolic parameters in obese adults in Serbia | Soskic S, Gluvic Z, Obradovic M, Ilincic B, Cabarkapa V, Stokic E, Isenovic E | 78. | AT223 | 2025 | E | EUROPEAN PHYSICAL JOURNAL C Vol. 85 (10): #1192 - (31), (DOI: 10.1140/epjc/s10052-025-14810-w) OCT 23 2025WOS | 1 | 0 | 443 | 0 | 0.0000 | The XLZD Design Book: towards the next-generation liquid xenon observatory for dark matter and neutrino physics | Aalbers J, Abe K, Adrover M, Maouloud S, Akerib D, Al M, Alder F, Althueser L, Amaral D, Amarasinghe C, Ames A, Andrieu B, Angelides N, Angelino E, Antunovic B, Aprile E, Araújo H, Armstrong J, Arthurs M, Babicz M, Baker A, Balzer M, Bang J, Barberio E, Bargemann J, Barillier E, Basharina-Freshville A, Baudis L, Bauer D, Bazyk M, ... |
|---|
27. 04. 2026.; 00:07:53; Trajanje procesiranja: 0.029 s
Legenda:
RB - redni broj rezultata
IBI - identifikacioni broj istraživača
Godina - godina u kojoj je rezultat publikovan (isključivo sa kompletnom paginacijom)
Kat - kategorija rezulata
Tip - tip rezultata (teorijski, simulacioni ili eksperimentalni)
Vrsta - vrsta rezultata
Referenca - referenca rezultata (bez autora i naslova rezultata) sa direktnim linkom na rezultat (ako ima DOI broj), sa linkom na zapis u eNauci ili WOS
TC - ukupan broj citata rezulata na dan 31. 1. 2026. godine
TCP - ukupan broj citata rezultata u periodu 2015-2024
BA - broj autora na rezultatu
NBB - normirani broj bodova rezultata
NTC - normirani broj citata rezultata u periodu 2015-2024
Naslov - naslov rezultata
Autori - spisak svih autora ili najviše prvih 30 autora
Primer:
Primer normiranja broja M poena i broja citata ostvarenih na jednom rezultatu: eksperimentalni rad sa 11 autora u časopisu kategorije M21a+ koji je publikovan 2020. godine, citiran je 65 puta, od čega 55 puta u periodu 2015-2024. godine.
Normirani broj M poena koje istraživač ostvaruje na rezultatu je 20/(1+0.2*(11-10))=16.6667 a normirani broj citata je 55/(1+0.2*(11-10))=45.8333.
Ukupan broj ostaverinih bodova utvrđuje se na naznačenom periodu za sabiranje normiranih M poena svakog istraživača i u periodu za određivanje ukupnog broja normiranih citata (2015-2024).